PPAR-delta endurance
Selected indexed studies
- Regulation of energy metabolism by long-chain fatty acids. (Prog Lipid Res, 2014) [PMID:24362249]
- PPAR delta as a therapeutic target in metabolic disease. (FEBS Lett, 2008) [PMID:18036566]
- Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway. (J Cell Mol Med, 2011) [PMID:20477906]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Regulation of energy metabolism by long-chain fatty acids. (2014) pubmed
- PPAR delta as a therapeutic target in metabolic disease. (2008) pubmed
- Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway. (2011) pubmed
- PPAR delta: a dagger in the heart of the metabolic syndrome. (2006) pubmed
- Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling. (2019) pubmed
- Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. (2005) pubmed
- Marathon mice: researcher view on potential roles in preclinical research. (2021) pubmed
- Conjugated linoleic acid (CLA) promotes endurance capacity via peroxisome proliferator-activated receptor δ-mediated mechanism in mice. (2016) pubmed
- Exercise Mimetics: Running Without a Road Map. (2017) pubmed
- Ethanolic Extract of Vaccinium corymbosum Alleviates Muscle Fatigue in Mice. (2020) pubmed